M O'Brien
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 4
-
- Retinoids in leukemia and cellular processes 3
- Co-authors
- Frank M. Balis (11 shared papers)Peter C. Adamson (9 shared papers)Brigitte C. Widemann (5 shared papers)Gregory H. Reaman (7 shared papers)Susan M. Blaney (5 shared papers)Robert F. Murphy (2 shared papers)Elizabeth Fox (2 shared papers)Michael Montello (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)European Journal of Cancer (1 paper)Blood (1 paper)Pediatric Blood & Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United States
In The Last Decade
M O'Brien
11 papers receiving 563 citations
Peers
Comparison fields: 5 of 62
- Hematology 94
- Public Health, Environmental and Occupational Health 180
- Neurology 81
- Genetics 49
- Biochemistry 26
Countries citing papers authored by M O'Brien
This map shows the geographic impact of M O'Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M O'Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M O'Brien more than expected).
Fields of papers citing papers by M O'Brien
This network shows the impact of papers produced by M O'Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M O'Brien. The network helps show where M O'Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside M O'Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 118 | |
| 2 | 1997 | 105 | |
| 3 | 2007 | 98 | |
| 4 | 1997 | 54 | |
| 5 | 1997 | 53 | |
| 6 | 2004 | 51 | |
| 7 | Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial. | 1999 | 44 |
| 8 | 2006 | 37 | |
| 9 | A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. | 1997 | 18 |
| 10 | 1998 | 14 | |
| 11 | 1999 | 1 |
About M O'Brien
M O'Brien is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Dermatology, Hematology and Infectious Diseases, having authored 11 papers that have together received 593 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Retinoids in leukemia and cellular processes (3 papers), Chemotherapy-related skin toxicity (2 papers), Acute Myeloid Leukemia Research (1 paper), Antioxidant Activity and Oxidative Stress (1 paper), Poisoning and overdose treatments (1 paper), HIV/AIDS drug development and treatment (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (94 citations), Public Health, Environmental and Occupational Health (180 citations), Neurology (81 citations), Genetics (49 citations) and Biochemistry (26 citations). M O'Brien has collaborated with scholars based in United States. Frequent co-authors include Frank M. Balis, Peter C. Adamson, Brigitte C. Widemann, Gregory H. Reaman, Susan M. Blaney, Robert F. Murphy, Elizabeth Fox, Michael Montello, John M. Sorensen and David G. Poplack. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Blood, Pediatric Blood & Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.